Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2015-09-24 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Interim Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT 2015' and contains detailed financial information for the six months ended 30 June 2015, including unaudited consolidated loss, net asset value, business and financial review, financial review, capital expenditure, risk of exchange rate, remuneration policy, and prospects. It includes condensed consolidated financial statements such as profit or loss, comprehensive income, financial position, changes in equity, and cash flows. The presence of these substantive financial data and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is about 15,000 characters, indicating it is the report itself, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2015
2015-09-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2015
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/8/2015, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities for Guangdong Tannery Limited. The content is a regulatory filing reporting monthly changes in share capital and securities movements, typical of a regulatory compliance report rather than a financial report or announcement. It does not contain financial statements, earnings data, or management commentary. The document length is about 13,841 characters, indicating a detailed report but focused on share capital movements. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2015-09-02 English
Interim Results Announcement for the six months ended 30 June 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2015' and contains detailed unaudited consolidated financial statements including profit or loss, comprehensive income, financial position, notes on accounting policies, segment information, revenue, expenses, tax, earnings per share, dividend declaration, receivables, and payables. The period covered is six months, indicating a half-year report. The document is about interim financial results with substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2015
2015-08-26 English
Date of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a short announcement from Guangdong Tannery Limited stating the date of a board meeting to approve interim results for the six months ended 30 June 2015. It does not contain any financial data or the actual interim report, but merely announces the meeting date and purpose. The document length is only 1339 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about upcoming board meetings to approve financial results are classified as Regulatory Filings (RNS) because they do not contain substantive financial data or the report itself.
2015-08-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2015
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/7/2015, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update. The document is lengthy (over 14,000 characters) and contains detailed data on share capital changes, not just an announcement or summary. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2015-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2015
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/6/2015, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities. The content is a regulatory disclosure about share capital changes and movements rather than a financial report, earnings release, or management discussion. It is a formal regulatory filing required by the exchange to report share capital movements. The document is lengthy (over 14,000 characters) and contains detailed tables of share capital movements, but it is not an annual or interim report, nor an earnings release or management report. It fits best under Regulatory Filings (RNS) as a general regulatory announcement about share capital movements that does not fit other specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a single event announcement.
2015-07-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.